TrialThe Journal of urology2024

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.

David Staskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.